Targeting influenza virosomes to ovarian carcinoma cells

19Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

Reconstituted influenza virus envelopes (virosomes) containing the viral hemagglutinin (HA) have attracted attention as delivery vesicles for cytosolic drug delivery as they possess membrane fusion activity. Here, we show that influenza virosomes can be targeted towards ovarian carcinoma cells (OVCAR-3) with preservation of fusion activity. This was achieved by incorporating poly(ethylene glycol) (PEG)-derivatized lipids into the virosome membrane. This PEG layer serves as shield to prevent interaction of HA with ubiquitous sialic acid residues and as spatial anchor for antibody attachment. Coupling of Fab′ fragments of mAb 323/A3 (anti-epithelial glycoprotein-2) to the distal ends of PEG lipids resulted in specific binding of virosomes to OVCAR-3 cells. These antibody-redirected virosomes fused with membranes of OVCAR-3 cells in a pH-dependent fashion. © 2001 Published by Elsevier Science B.V. on behalf of the Federation of European Biochemical Societies.

Cite

CITATION STYLE

APA

Mastrobattista, E., Schoen, P., Wilschut, J., Crommelin, D. J. A., & Storm, G. (2001). Targeting influenza virosomes to ovarian carcinoma cells. FEBS Letters, 509(1), 71–76. https://doi.org/10.1016/S0014-5793(01)03112-X

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free